FANCA and lip and oral cavity carcinoma: To this end, biallelic inactivation of FANCA, the gene most frequently mutated in FA patients (60%), was achieved by CRISPR/Cas9 editing of CAL27 and CAL33 non-FA, two well-known oral cancer cell lines.